Immunogenicity, Reactogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Rotarix Porcine Circovirus (PCV)-Free Liquid Compared to Rotarix Liquid Given in 2-doses in Healthy Chinese Infants Starting at Age 6-16 Weeks

Inclusion Criteria: * Participants' parent(s)/legally acceptable representative(s) \[LAR(s)\], who, in the opinion of the investigator, can and will comply with the requirements of the protocol. * Written or witnessed/thumb printed informed consent obtained from the parent(s)/LAR(s) of the participant prior to performance of any study specific procedure. * A male or female with Chinese origin, between, and including, 6 and 16 weeks (42-112 days) of age at the time of the first study intervention administration. * Healthy participants as established by medical history and clinical examination before entering into the study. * Born after a gestation period of 36 to 42 weeks inclusive. Exclusion Criteria: Medical conditions * Any confirmed or suspected immunosuppressive or immunodeficient condition, based on medical history and physical examination (no laboratory testing required). * History of severe combined immunodeficiency. * History of any reaction or hypersensitivity likely to be exacerbated by any component of the study intervention. * History of seizures or progressive neurological disease. * Family history of congenital or hereditary immunodeficiency. * Uncorrected congenital malformation of the gastrointestinal tract that would predispose for intussusception (IS). * History of IS. * Major congenital defects, or serious chronic illness as assessed by the investigator. * Previous confirmed occurrence of rotavirus gastroenteritis (RVGE). * Participants with confirmed …